Integrated Diag Hdgs - Director/PDMR Shareholding
RNS Number : 0230RIntegrated Diagnostics Holdings PLC17 August 202617 August 2026
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
The notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Hena Holdings Ltd
2
Reason for the notification
a)
Position/status
PCA of Dr Hend El Sherbini, Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Integrated Diagnostics Holdings plc
b)
LEI
2138007JN9NUWKKTS790
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code:
Ordinary shares of $0.25 each in Integrated Diagnostics Holdings plc
JE00BLKGSR75
b)
Nature of the transaction
Acceptances to mandatory offer
c)
Price(s) and volume(s)
Currency
Price(s)
Volume(s)
USD
0.50
24,043
d)
Aggregated information
- Aggregated volume
- Price
- Total
Volume: 24,043
Price: USD 0.50 per share
Total: USD 12,021.50
e)
Date of the transaction
12 August 2026
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBLGDISDBDGLR